BeiGene

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About ONC

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.

CEO

John V. Oyler

CEOJohn V. Oyler

Employees

11,000

Employees11,000

Headquarters

Basel, Basel-Landschaft (Basle Country)

HeadquartersBasel, Basel-Landschaft (Basle Country)

Founded

2010

Founded2010

Employees

11,000

Employees11,000

ONC Key Statistics

Market cap

38.30B

Market cap38.30B

Price-Earnings ratio

649.98

Price-Earnings ratio649.98

Dividend yield

—

Dividend yield—

Average volume

264.69K

Average volume264.69K

High today

$332.64

High today$332.64

Low today

$317.50

Low today$317.50

Open price

$332.64

Open price$332.64

Volume

106.85K

Volume106.85K

52 Week high

$385.22

52 Week high$385.22

52 Week low

$170.99

52 Week low$170.99

Stock Snapshot

As of today, BeiGene(ONC) shares are valued at $319.49. The company's market cap stands at 38.3B, with a P/E ratio of 649.98.

As of 2025-12-05, BeiGene(ONC) stock has fluctuated between $317.50 and $332.64. The current price stands at $319.49, placing the stock +0.6% above today's low and -4.0% off the high.

BeiGene(ONC) shares are trading with a volume of 106.85K, against a daily average of 264.69K.

During the past year, BeiGene(ONC) stock moved between $170.99 at its lowest and $385.22 at its peak.

Analyst ratings

97%

of 30 ratings

Buy

96.7%

Hold

3.3%

Sell